A 2 x 5 weeks open label, multicenter, randomized cross-over study to compare the reduction of predialysis systolic blood pressure with valsartan (Diovan) 80 mg compared to irbesartan150 mg in patients with mild to moderate hypertension on long-term hemodialysis

The primary efficacy variable is predialytic MSSBP after 4 weeks treatment with valsartan 80 mg and irbesartan 150 mg.

Kusajili – Clinical trials directory